id todo:paper_03014851_v40_n4_p3015_SBelforte
record_format dspace
spelling todo:paper_03014851_v40_n4_p3015_SBelforte2023-10-03T15:18:28Z Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis S. Belforte, F. Coluccio Leskow, F. Poskus, E. Penas Steinhardt, A. D299G Diabetes Meta-analysis Metabolic syndrome Polymorphism TLR4 toll like receptor 4 article Caucasian cell interaction Crohn disease digestive system cancer disease association enteritis ethnicity gene frequency geographic distribution human metabolic disorder non insulin dependent diabetes mellitus protein polymorphism systematic review ulcerative colitis Diabetes Mellitus, Type 2 European Continental Ancestry Group Genetic Predisposition to Disease Humans Immunity, Innate Inflammatory Bowel Diseases Insulin Resistance Lipopolysaccharides Metabolic Syndrome X Phenotype Polymorphism, Single Nucleotide Risk Factors Toll-Like Receptor 4 The toll-like receptor 4 (TLR4) plays a key role in the activation of innate immune response participating in the recognition of lipopolysaccharides. Changes in the innate immune response are involved in the pathogenesis of some metabolic disorders such as metabolic syndrome and type 2 diabetes mellitus (Met-S and T2DM). It has been recently shown the role of gut microbiota in the perpetuation of both insulin resistance and low-grade chronic inflammation. Some studies have reported that TLR4 D299G polymorphism is associated with metabolic disorders, however results have been inconsistent. Two recent meta-analyses showed that D299G is associated with inflammatory bowel disease and gastrointestinal cancers risk, two pathological states in which the luminal microbial flora-host cells interaction may be implicated. We conducted a systemic review of the published data considering all eligible published studies (six studies with 1696 cases and 3388 controls for D299G) and a meta-analysis was performed to evaluate the association between TLR4 D299G polymorphism and the risk for metabolic disorders. Five studies were identified for T2DM: three corresponding to Caucasian populations and two to mixed populations. The remaining study analyzed Met-S in a Caucasian population. We observed a significant association between D299G polymorphism and metabolic disorders (T2DM and Met-S) risk (OR = 0.566, 95 % CI: 0.347-0.925, p = 0.023) particularly in Caucasians. No association was found in mixed population subgroup. Our meta-analysis identified that the AG/GG genotypes of D299G are associated with decreased metabolic disorders risk. © 2012 Springer Science+Business Media Dordrecht. Fil:Coluccio Leskow, F. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03014851_v40_n4_p3015_SBelforte
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic D299G
Diabetes
Meta-analysis
Metabolic syndrome
Polymorphism
TLR4
toll like receptor 4
article
Caucasian
cell interaction
Crohn disease
digestive system cancer
disease association
enteritis
ethnicity
gene frequency
geographic distribution
human
metabolic disorder
non insulin dependent diabetes mellitus
protein polymorphism
systematic review
ulcerative colitis
Diabetes Mellitus, Type 2
European Continental Ancestry Group
Genetic Predisposition to Disease
Humans
Immunity, Innate
Inflammatory Bowel Diseases
Insulin Resistance
Lipopolysaccharides
Metabolic Syndrome X
Phenotype
Polymorphism, Single Nucleotide
Risk Factors
Toll-Like Receptor 4
spellingShingle D299G
Diabetes
Meta-analysis
Metabolic syndrome
Polymorphism
TLR4
toll like receptor 4
article
Caucasian
cell interaction
Crohn disease
digestive system cancer
disease association
enteritis
ethnicity
gene frequency
geographic distribution
human
metabolic disorder
non insulin dependent diabetes mellitus
protein polymorphism
systematic review
ulcerative colitis
Diabetes Mellitus, Type 2
European Continental Ancestry Group
Genetic Predisposition to Disease
Humans
Immunity, Innate
Inflammatory Bowel Diseases
Insulin Resistance
Lipopolysaccharides
Metabolic Syndrome X
Phenotype
Polymorphism, Single Nucleotide
Risk Factors
Toll-Like Receptor 4
S. Belforte, F.
Coluccio Leskow, F.
Poskus, E.
Penas Steinhardt, A.
Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis
topic_facet D299G
Diabetes
Meta-analysis
Metabolic syndrome
Polymorphism
TLR4
toll like receptor 4
article
Caucasian
cell interaction
Crohn disease
digestive system cancer
disease association
enteritis
ethnicity
gene frequency
geographic distribution
human
metabolic disorder
non insulin dependent diabetes mellitus
protein polymorphism
systematic review
ulcerative colitis
Diabetes Mellitus, Type 2
European Continental Ancestry Group
Genetic Predisposition to Disease
Humans
Immunity, Innate
Inflammatory Bowel Diseases
Insulin Resistance
Lipopolysaccharides
Metabolic Syndrome X
Phenotype
Polymorphism, Single Nucleotide
Risk Factors
Toll-Like Receptor 4
description The toll-like receptor 4 (TLR4) plays a key role in the activation of innate immune response participating in the recognition of lipopolysaccharides. Changes in the innate immune response are involved in the pathogenesis of some metabolic disorders such as metabolic syndrome and type 2 diabetes mellitus (Met-S and T2DM). It has been recently shown the role of gut microbiota in the perpetuation of both insulin resistance and low-grade chronic inflammation. Some studies have reported that TLR4 D299G polymorphism is associated with metabolic disorders, however results have been inconsistent. Two recent meta-analyses showed that D299G is associated with inflammatory bowel disease and gastrointestinal cancers risk, two pathological states in which the luminal microbial flora-host cells interaction may be implicated. We conducted a systemic review of the published data considering all eligible published studies (six studies with 1696 cases and 3388 controls for D299G) and a meta-analysis was performed to evaluate the association between TLR4 D299G polymorphism and the risk for metabolic disorders. Five studies were identified for T2DM: three corresponding to Caucasian populations and two to mixed populations. The remaining study analyzed Met-S in a Caucasian population. We observed a significant association between D299G polymorphism and metabolic disorders (T2DM and Met-S) risk (OR = 0.566, 95 % CI: 0.347-0.925, p = 0.023) particularly in Caucasians. No association was found in mixed population subgroup. Our meta-analysis identified that the AG/GG genotypes of D299G are associated with decreased metabolic disorders risk. © 2012 Springer Science+Business Media Dordrecht.
format JOUR
author S. Belforte, F.
Coluccio Leskow, F.
Poskus, E.
Penas Steinhardt, A.
author_facet S. Belforte, F.
Coluccio Leskow, F.
Poskus, E.
Penas Steinhardt, A.
author_sort S. Belforte, F.
title Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis
title_short Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis
title_full Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis
title_fullStr Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis
title_full_unstemmed Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis
title_sort toll-like receptor 4 d299g polymorphism in metabolic disorders: a meta-analysis
url http://hdl.handle.net/20.500.12110/paper_03014851_v40_n4_p3015_SBelforte
work_keys_str_mv AT sbelfortef tolllikereceptor4d299gpolymorphisminmetabolicdisordersametaanalysis
AT coluccioleskowf tolllikereceptor4d299gpolymorphisminmetabolicdisordersametaanalysis
AT poskuse tolllikereceptor4d299gpolymorphisminmetabolicdisordersametaanalysis
AT penassteinhardta tolllikereceptor4d299gpolymorphisminmetabolicdisordersametaanalysis
_version_ 1807314414989213696